Influence of DHA-rich Supplement on DHA-status and Health Evolution of Patients With Cystic Fibrosis

Ghent University Hospital (UZ)

Status and phase: Completed; Phase 2

Conditions: Cystic Fibrosis

Treatments: Drug: Giving DHA-rich supplement

Study type: Interventional

Funder types: Other

Identifiers

NCT00221546

2001/220

Details and patient eligibility

About

Investigation of the influence of giving DHA-rich supplement versus placebo on DHA-status and health evolution of patients with cystic fibrosis

Full description

Investigation of the influence of giving DHA-rich supplement versus placebo on DHA-status and health evolution of patients with cystic fibrosis

Enrollment: 17 patients

Sex: All

Ages: 6+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Delta F 508 homozygote
• Stable clinical situation

Exclusion criteria

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: Triple Blind

---

17 participants in 2 patient groups, including a placebo group

DHA-rich supplement

Active Comparator group

Treatment:

Drug: Giving DHA-rich supplement

Placebo

Placebo Comparator group

Treatment:

Drug: Giving DHA-rich supplement